Humoral Alloreactivity in VCA Recipients: Should We Learn from Our Experience?

Initially overlooked in favor of T-cell mediated rejection, the importance of the humoral alloimmune response has progressively emerged. As a result, antibody-mediated rejection (AMR) is now widely recognized as the main cause of late allograft loss in most (if not all) types of solid organ transplantation.Over the last 2 decades, vascularized composite allotransplantation (VCA) has appeared for replacing tissue defects in patients for whom no other satisfactory reconstructive options were available.Although it is now clear that VCA recipients can develop donor-specific antibodies, conclusions made in solid organ transplantation regarding AMR may not systematically apply to VCA.Here, we propose to use the experience gained in organ transplantation to shed light on the path that shall be followed to evaluate and manage humoral alloreactivity in VCA recipients.